We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.09B
AUM Growth
+$1.38B
Cap. Flow
+$926M
Cap. Flow %
18.19%
Top 10 Hldgs %
35.13%
Holding
112
New
25
Increased
38
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$137M
2
AGN.PRA
Allergan plc
AGN.PRA
+$89.2M
3
CNC icon
Centene
CNC
+$76.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.1M
5
JD icon
JD.com
JD
+$52M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$243M
2
UHS icon
Universal Health Services
UHS
+$91.1M
3
PCRX icon
Pacira BioSciences
PCRX
+$87.8M
4
MCK icon
McKesson
MCK
+$72.1M
5
BABA icon
Alibaba
BABA
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.12%
2 Technology 12.48%
3 Communication Services 5.27%
4 Consumer Discretionary 4.56%
5 Financials 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
CALL
Centene
CNC
$31.3B
$69.3M 1.36%
+1,432,600
New +$61.7M
MYOK
27
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$69.3M 1.36%
1,616,954
-52,570
-3% -$1.68M
JUNO
28
DELISTED
Juno Therapeutics, Inc.
JUNO
$65.1M 1.28%
1,450,607
+1,335,912
+1,165% +$45.5M
BABA icon
29
Alibaba
BABA
$269B
$62.9M 1.24%
364,341
-338,705
-48% -$54.9M
NOW icon
30
ServiceNow
NOW
$102B
$62M 1.22%
2,635,950
-457,730
-15% -$10.2M
UNH icon
31
UnitedHealth
UNH
$382B
$59.7M 1.17%
305,072
-23,757
-7% -$4.59M
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$58.1M 1.14%
+231,451
New +$57.1M
BOX icon
33
Box
BOX
$4.02B
$56M 1.1%
2,896,214
+1,642,335
+131% +$30.9M
MDCO
34
DELISTED
Medicines Co
MDCO
$55.6M 1.09%
1,501,003
-311,999
-17% -$11.5M
PFE icon
35
Pfizer
PFE
$140B
$54.6M 1.07%
+1,613,081
New +$51.8M
PEN icon
36
Penumbra
PEN
$12.5B
$53.3M 1.05%
590,673
+163,668
+38% +$14.1M
MOH icon
37
Molina Healthcare
MOH
$10.3B
$49.2M 0.97%
716,094
-164,308
-19% -$10.7M
NFLX icon
38
Netflix
NFLX
$292B
$49.1M 0.97%
+2,709,290
New +$47.3M
HUM icon
39
Humana
HUM
$46.7B
$49M 0.96%
201,190
-135,117
-40% -$33.1M
PYPL icon
40
PayPal
PYPL
$49.5B
$48.1M 0.95%
751,075
+375,676
+100% +$22.5M
INCY icon
41
PUT
Incyte
INCY
$23.5B
$47.7M 0.94%
+409,000
New +$51.7M
RVTY icon
42
Revvity
RVTY
$12.3B
$46.5M 0.91%
674,267
+85,727
+15% +$5.75M
DXC icon
43
DXC Technology
DXC
$1.63B
$40.2M 0.79%
541,424
-362,428
-40% -$25.7M
XBI icon
44
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$39.9M 0.78%
+461,125
New +$37M
PANW icon
45
Palo Alto Networks
PANW
$264B
$38.5M 0.76%
1,604,994
– –
META icon
46
CALL
Meta Platforms (Facebook)
META
$1.51T
$38.4M 0.75%
+224,700
New +$37.5M
EVH icon
47
Evolent Health
EVH
$475M
$36.7M 0.72%
2,063,033
+1,614,855
+360% +$33.3M
KURA icon
48
Kura Oncology
KURA
$922M
$36.1M 0.71%
2,411,552
+374,059
+18% +$3.51M
SNNA
49
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$35.2M 0.69%
+1,580,410
New +$34.7M
SPGI icon
50
S&P Global
SPGI
$126B
$34.9M 0.69%
223,475
-35,174
-14% -$5.35M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2017 Portfolio in Review

As of Q3 2017, PFM Health Sciences held 112 positions worth $5.09B, up 37% from $3.71B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences deployed $926M of net new capital in Q3 2017, opening 25 new positions and adding to 38 existing holdings. Its largest new stake was Allergan plc: 107,410 shares worth $79.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $243M trimmed.

  • PFM Health Sciences's largest Q3 2017 buy was Allergan plc: 107,410 shares worth $79.2M.
  • PFM Health Sciences added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $137M increase.
  • PFM Health Sciences's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $243M.
  • PFM Health Sciences fully exited Universal Health Services in Q3 2017, selling an estimated $91.1M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $5.09B portfolio in Q3 2017.
  • PFM Health Sciences opened 25 new positions and closed 24 in Q3 2017.
  • PFM Health Sciences's portfolio value rose 37% quarter-over-quarter to $5.09B.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.